Brazil halves medtech import growth forecast as strike impact persists
This article was originally published in Clinica
Executive Summary
Around 70% of medtech importers to Brazil were expecting to take at least two months or more to recover fully from this summer's six-week public strike that involved the country's regulatory agency Anvisa. This is one of the views that emerged from a survey conducted in the first week of September by Brazil's leading medtech importers association, Abimed.